Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trialKoichi Node, Sho Komukai, Yoshisato Shibata et al.|Heart and Vessels|2018Cited by 11